Mechanisms of maternal antibody interference with rotavirus vaccination

ABSTRACT: Maternal antibodies are transferred transplacentally to fetuses and then through lactation to infants to protect them whilst their own immune system is still immature. However, these antibodies also suppress neonatal B-cell responses, thereby impairing vaccine efficacy and leaving infants potentially vulnerable to life-threatening pathogens, such as rotaviruses. Currently available rotavirus vaccines are composed of live-attenuated viral strains administered to infants orally when they become 6-8 weeks old. Although high concentrations of maternal antibodies correlate with poor production of antibodies following vaccination (i.e., seroconversion), the immunological basis of this interference is unknown. To investigate the underlying mechanisms, we here developed a mouse model of neonatal o

SUBMITTER: Tawny, L Chandler 

PROVIDER: S-SCDT-10_1038-S44318-025-00582-2 | biostudies-other |

REPOSITORIES: biostudies-other